BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 32916316)

  • 21. PharmFrag: An Easy and Fast Multiplex Pharmacogenetics Assay to Simultaneously Analyze 9 Genetic Polymorphisms Involved in Response Variability of Anticancer Drugs.
    Bouvet R; Verdier MC; El Baroudi Y; Galibert MD; David V; Schutz S; Tron C
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33348915
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Marking off new territory in the search for anticancer compounds: epigenetic mechanisms add complexity and promise to cancer research efforts.
    Nelson B
    Cancer Cytopathol; 2012 Jun; 120(3):143-4. PubMed ID: 22692980
    [No Abstract]   [Full Text] [Related]  

  • 23. Pharmacogenetic application in personalized cancer treatment.
    Kristyanto H; Utomo AR
    Acta Med Indones; 2010 Apr; 42(2):109-15. PubMed ID: 20513938
    [TBL] [Abstract][Full Text] [Related]  

  • 24. IMPACT web portal: oncology database integrating molecular profiles with actionable therapeutics.
    Hintzsche JD; Yoo M; Kim J; Amato CM; Robinson WA; Tan AC
    BMC Med Genomics; 2018 Apr; 11(Suppl 2):26. PubMed ID: 29697364
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CYP450 pharmacogenetics for personalizing cancer therapy.
    van Schaik RH
    Drug Resist Updat; 2008 Jun; 11(3):77-98. PubMed ID: 18486526
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacogenetics in clinical practice: how far have we come and where are we going?
    Johnson JA
    Pharmacogenomics; 2013 May; 14(7):835-43. PubMed ID: 23651030
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacogenetics in oncology: a promising field.
    Houtsma D; Guchelaar HJ; Gelderblom H
    Curr Pharm Des; 2010; 16(2):155-63. PubMed ID: 20205661
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacogenetic Predictors of Response.
    Hertz DL; Rae JM
    Adv Exp Med Biol; 2016; 882():191-215. PubMed ID: 26987536
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacogenetics: transforming clinical medicine.
    Newman WG
    J R Coll Physicians Edinb; 2012; 42(3):244-7. PubMed ID: 22953321
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Update on pharmacogenetics in cancer chemotherapy.
    Innocenti F; Ratain MJ
    Eur J Cancer; 2002 Mar; 38(5):639-44. PubMed ID: 11916544
    [TBL] [Abstract][Full Text] [Related]  

  • 31. On the use of pharmacogenetics in cancer treatment and clinical trials.
    Robert J; Le Morvan V; Giovannetti E; Peters GJ;
    Eur J Cancer; 2014 Oct; 50(15):2532-43. PubMed ID: 25103456
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacogenetics in gastrointestinal tumors.
    Stöhlmacher J
    Onkologie; 2005 Aug; 28(8-9):435-40. PubMed ID: 16160407
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluating the consistency of large-scale pharmacogenomic studies.
    Rahman R; Dhruba SR; Matlock K; De-Niz C; Ghosh S; Pal R
    Brief Bioinform; 2019 Sep; 20(5):1734-1753. PubMed ID: 31846027
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cancer pharmacogenetics.
    Marsh S
    Methods Mol Biol; 2008; 448():437-46. PubMed ID: 18370241
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacogenomics of cetuximab in metastatic colorectal carcinoma.
    Silvestris N; Vincenzi B; Brunetti AE; Loupakis F; Dell'Aquila E; Russo A; Scartozzi M; Giampieri R; Cascinu S; Lorusso V; Tonini G; Falcone A; Santini D
    Pharmacogenomics; 2014 Sep; 15(13):1701-15. PubMed ID: 25410895
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The evolving war on cancer.
    Haber DA; Gray NS; Baselga J
    Cell; 2011 Apr; 145(1):19-24. PubMed ID: 21458664
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ontology development for a pharmacogenetics knowledge base.
    Oliver DE; Rubin DL; Stuart JM; Hewett M; Klein TE; Altman RB
    Pac Symp Biocomput; 2002; ():65-76. PubMed ID: 11928517
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Application of genotype-guided cancer therapy in solid tumors.
    Patel JN
    Pharmacogenomics; 2014 Jan; 15(1):79-93. PubMed ID: 24329193
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Personalizing supportive care in oncology patients using pharmacogenetic-driven treatment pathways.
    Andersen RL; Johnson DJ; Patel JN
    Pharmacogenomics; 2016 Mar; 17(4):417-34. PubMed ID: 26871520
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacogenetics and pediatric cancer.
    Bomgaars L; McLeod HL
    Cancer J; 2005; 11(4):314-23. PubMed ID: 16197721
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.